# Family Health International 360

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/family-health-international-360/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 26.3 |
| Citations | 575,116 |
| City | Durham |
| Country | US |
| Description | Family Health International 360 is a research organisation in Durham, US. OpenAlex records 5,079 works and 575,116 citations for it. 958 researchers list it as their most recent affiliation. |
| Homepage | http://www.fhi360.org/ |
| OpenAlex ID | https://openalex.org/I1290866511 |
| Researchers | 958 |
| ROR ID | https://ror.org/007kp6q87 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q5433149 |
| Works | 5,079 |

## University papers

Showing 12 of 15.

- [The burden of Duchenne muscular dystrophy](https://scholariq.org/papers/the-burden-of-duchenne-muscular-dystrophy/)
- [Quantifying the burden of caregiving in Duchenne muscular dystrophy](https://scholariq.org/papers/quantifying-the-burden-of-caregiving-in-duchenne-muscular-dystrophy/)
- [Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-duchenne-muscular-dystrophy-a/)
- [Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data](https://scholariq.org/papers/cost-effectiveness-of-four-immunomodulatory-therapies-for-relapsing-remitting/)
- [Compliance to Care Guidelines for Duchenne Muscular Dystrophy](https://scholariq.org/papers/compliance-to-care-guidelines-for-duchenne-muscular-dystrophy/)
- [Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine](https://scholariq.org/papers/treating-early-versus-treating-mild-timing-of-migraine-prescription-medications/)
- [A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy](https://scholariq.org/papers/a-randomized-controlled-trial-of-gabapentin-enacarbil-in-subjects-with/)
- [&lt;p&gt;Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs&lt;/p&gt;](https://scholariq.org/papers/and-lt-p-and-gt-real-world-effectiveness-of-mepolizumab-in-patients-with-severe/)
- [Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States](https://scholariq.org/papers/results-of-an-economic-model-to-assess-the-cost-effectiveness-of-enoxaparin-a/)
- [Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA](https://scholariq.org/papers/real-world-effectiveness-of-sotrovimab-for-the-early-treatment-of-covid-19/)
- [The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States](https://scholariq.org/papers/the-cost-of-flares-among-patients-with-systemic-lupus-erythematosus-with-and/)
- [Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study](https://scholariq.org/papers/clinical-and-economic-burden-of-systemic-lupus-erythematosus-in-the-years/)

## University researchers

- [Christopher F. Bell](https://scholariq.org/researchers/christopher-f-bell/)

## University top topics

Showing 8 of 25.

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [Adolescent Sexual and Reproductive Health](https://scholariq.org/topics/adolescent-sexual-and-reproductive-health/)
- [Reproductive Health and Contraception](https://scholariq.org/topics/reproductive-health-and-contraception/)
- [Global Maternal and Child Health](https://scholariq.org/topics/global-maternal-and-child-health/)
- [Reproductive tract infections research](https://scholariq.org/topics/reproductive-tract-infections-research/)
- [HIV, Drug Use, Sexual Risk](https://scholariq.org/topics/hiv-drug-use-sexual-risk/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [Sex work and related issues](https://scholariq.org/topics/sex-work-and-related-issues/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
